Product Information
AZITHROMYCIN 200 MG/5 ML SUSP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2313 per ML under NDC 00093202694. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jul 5, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/5mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093202694
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AZITHROMYCIN MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA065246FDA Approved
7/5/2006
TE Code
AB
On Market Since
12/17/2010
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 48.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2313 per ML |
|---|---|
| All-time high | $0.6374 (Sep 10, 2014) |
| All-time low | $0.1988 (Nov 20, 2024) |
| 52-week high | $0.2580 |
| 52-week low | $0.2231 |
| Median price | $0.4164 |
| Average price | $0.4179 |
| Largest weekly change | +27.9% (Jun 18, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AZITHROMYCIN 200 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN 200 MG/5 ML SUSP, manufactured by Teva Pharmaceuticals USA Inc., is $0.2313 per ML (NDC 00093202694), effective Aug 19, 2026.
How has the price of AZITHROMYCIN 200 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has declined 48.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN 200 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has ranged from a low of $0.1988 (Nov 20, 2024) to a high of $0.6374 (Sep 10, 2014), with a median of $0.4164 per ML.
Are there cheaper alternatives to AZITHROMYCIN 200 MG/5 ML SUSP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AZITHROMYCIN 200 MG/5 ML SUSP, is $0.2095 per ML — about 9% below AZITHROMYCIN 200 MG/5 ML SUSP.
Who manufactures AZITHROMYCIN 200 MG/5 ML SUSP?
AZITHROMYCIN 200 MG/5 ML SUSP (NDC 00093202694) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.